Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field.
Zedira has offered more than 200 specialty reagents for transglutaminase-related R&D for about 15 years. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products.
More information >>
All Zedira Products
.
